The homeless intravenous drug abuser and the AIDS epidemic.

NIDA Res Monogr

The Homeless Project, State of New York Division of Substance Abuse Services, NY 10027.

Published: March 1990

Download full-text PDF

Source

Publication Analysis

Top Keywords

homeless intravenous
4
intravenous drug
4
drug abuser
4
abuser aids
4
aids epidemic
4
homeless
1
drug
1
abuser
1
aids
1
epidemic
1

Similar Publications

Background: Biased language in provider documentation of marginalized patient populations has been shown to negatively influence patient management. There has been debate over the use of "homeless" as a descriptor of people experiencing homelessness (PEH), as it is a potentially biased term with negative connotations. This study explores the relationship between the use of the word "homeless" in Emergency Department (ED) provider documentation and admission rates, as well as intravenous (IV) vs.

View Article and Find Full Text PDF

Background: People who inject drugs (PWID) are at high risk of blood-borne infections, and injection drug use contributes significantly to hepatitis C virus (HCV) transmission. The WHO has therefore set targets of reducing HCV incidence and prevalence among PWID and increasing treatment coverage to eliminate HCV by 2030. The DRUCK study (2011-2014) found high HCV prevalence and low treatment coverage among PWID in Germany.

View Article and Find Full Text PDF

Self-reported lifetime Hepatitis B virus testing, and vaccination uptake among people who inject drugs in Iran: a nationwide study in 2020.

BMC Public Health

November 2024

HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran.

Article Synopsis
  • Hepatitis B virus (HBV) infection is a significant public health issue among people who inject drugs (PWID), highlighting the importance of testing and vaccination to reduce infection rates and chronic health issues.
  • A study of 2,684 PWID in Iran revealed that only 14.2% reported having been tested for HBV, while 16.4% had been vaccinated, with factors such as academic education and a history of homelessness influencing these rates.
  • The findings indicate a crucial need to identify and overcome barriers preventing PWID from accessing HBV testing and vaccination to alleviate the impact of HBV within this vulnerable demographic.
View Article and Find Full Text PDF

Background: Addiction medicine providers have a key role in HIV prevention amidst rising HIV incidence in persons who inject drugs (PWID). Pre-exposure prophylaxis (PrEP) and post-exposure prophylaxis (PEP) are vastly underutilized in this population. Inpatient hospitalization represents a potential touchpoint for initiation of HIV prophylaxis, though little research explores the role of addiction providers.

View Article and Find Full Text PDF

Background: Limited data exists about treatment outcomes in nationwide hepatitis C virus (HCV) elimination programs where injection drug use (IDU) is the main mode of transmission. In 2016 Iceland initiated the HCV elimination program known as Treatment as Prevention for Hepatitis C (TraP HepC). Factors associated with HCV cure in this population are examined.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!